Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

01. Juni 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3014


	Artikel 1 - 20 / 60271

	Depression and increased cancer risk: a 10-year population-based cohort study. Soc Psychiatry Psychiatr Epidemiol Baek CH, Kim HJ, Son M, Kim HR, Kim SH, Kim HS. PMID: 42223651 [PubMed - as supplied by publisher]
	Expert Validation of an Artificial Intelligence-Enabled Trial Matching Solution Using Real-World Data From Patients With Cancer. JCO Oncol Pract Patel JN, Maher MC, Morris V, Sha W, Terry M, Wilson L, Yano R, Jongeneel P, Ahmed F, Subramanian CR, Zappas A, Singh P, Baxi S, Nikolic O, Mesa RA, Voorhees P, Farhangfar CJ, Butera P. PMID: 42223138 [PubMed - as supplied by publisher]
	Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer. N Engl J Med O'Reilly EM, Wainberg ZA, Hendifar AE, Borad MJ, Pietrantonio F, Pant S, Hammel P, Cremolini C, Manji GA, Oberstein PE, Garrido-Laguna I, Springfeld C, Azad NS, Ueno M, Chui SY, Zhang Y, Patel H, Lee Y, Salman Z, Wolpin BM, RASolute 302 Trial Investigators. PMID: 42223072 [PubMed - as supplied by publisher]
	Anti-Cancer Research Progress of Triptolide: Mechanisms of Action, Structural Modifications, Nanodelivery Systems and Clinical Challenges. Drug Des Devel Ther Li ZX, Zang L, Li YQ, Zhang M, Zhao DM, Han XY, Zhao JF, Ding CH, Liu WS. PMID: 42221354 [PubMed - indexed for MEDLINE]
	Polypharmacy in Elderly Patients Receiving First-Line Treatment for Pancreatic Adenocarcinoma: Analysis of Potential Drug-Drug Interactions and Outcome. Oncol Res Vecchia S, Chinelli R, Orcesi A, Citterio C, Riva A, Orlandi E. PMID: 42220431 [PubMed - indexed for MEDLINE]
	Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study. Br J Clin Pharmacol Yokokawa T, Tsuji D, Hatori M, Kawakami K, Nakao M, Yano T, Arakawa Y, Matsuo K, Ohashi Y, Ozaka M, Sasahira N, Sakata Y, Kogure Y, Tamaki S, Wada A, Taki Y, Suzuki W, Kobayashi K, Ishii H, Itoh K, Yamaguchi M, Suzuki K. PMID: 42220058 [PubMed - as supplied by publisher]
	Non-ablative focused ultrasound induces an adaptive immune response to suppress pancreatic cancer: a preclinical study. Ultrasonography Park EJ, Ahn Y, Cheon Y, Lee JY. PMID: 42220052 [PubMed]
	Application of small interfering RNAs and drug combination for pancreatic cancer therapy. J Drug Target Zeng C, Chen SZ. PMID: 42219546 [PubMed - as supplied by publisher]
	Quantifying Weight Loss Prior to Pancreatic Cancer Diagnosis: A Systematic Review and Meta-Analysis. Cancer Med Price CA, Cooke D, Mold F, Smith NAS, Winn M, Lemanska A. PMID: 42219540 [PubMed - indexed for MEDLINE]
	Current advances in immunotherapy for KRAS-Mutant pancreatic cancer. Clin Exp Med Li M, Wang X, Li P, Gong H, Wu J, Mao Y. PMID: 42218726 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Prognostic Value of Circulating Exosomal DNA in Esophageal Squamous Cell Carcinoma: A Prospective Cohort Study. Ann Surg Oncol Nakai T, Kitahata Y, Hiraki H, Nakamura Y, Motobayashi H, Takemoto N, Hyo T, Sato M, Ojima T, Hayata K, Goda T, Kitadani J, Tominaga S, Hayami S, Miyamoto A, Yamaue H, Iwaya T, Nishizuka S, Kawai M. PMID: 42218348 [PubMed - as supplied by publisher]
	RAD1 promotes oxaliplatin resistance in gastric cancer by reinforcing NRF2-driven antioxidant defense and DDR checkpoint signaling. Drug Resist Updat Zhou B, Zhang S, Shen Z, Si Y, Luo T, Shen H, Wei W, Yang Q, Duan M, Wang Z, Feng S, Xu A. PMID: 42217457 [PubMed - as supplied by publisher]
	Efficacy and Safety of Modified GTX as Second-Line Therapy in Advanced Pancreatic Adenocarcinoma: A Prospective Cohort Study. J Gastrointest Cancer Meski SE, Al Tartir R, Nassar F, Mezher M, Shamseddine A, Temraz S. PMID: 42216989 [PubMed - indexed for MEDLINE]
	GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review. Dis Mon Parekh RS, Inban P, Thai A, Agrawal A, Kudaiarov D, Tariq H. PMID: 42215399 [PubMed - as supplied by publisher]
	Corrigendum to "SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer" [Radiother. Oncol. 155 (2021) 278-284]. Radiother Oncol Holyoake DLP, Robinson M, Silva M, Grose D, McIntosh D, Sebag-Montefiore D, Radhakrishna G, Mukherjee S, Hawkins MA. PMID: 42214926 [PubMed - as supplied by publisher]
	Current opinions on CEA in the diagnosis and prognosis of colorectal cancer. Transl Oncol Han Q, Zhu Y, Xing F, Xia Y. PMID: 42214175 [PubMed - as supplied by publisher]
	Genetic and Clinical Features in TP53-Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next-Generation Sequencing Data. Cancer Rep (Hoboken) Cheng Y, Liu L, Gao Y, Wang Y, Zhu W, Chen H, Qin J, Zhang Y. PMID: 42213496 [PubMed - indexed for MEDLINE]
	Cancer vaccines: comprehensive review. BJS Open Clifford RE, Manu N, Yang Q, Arif Z, Aggen D, Bryan ME, Gupta A, Shaw H, Church D, Corrie P, Savelyeva N, Ottensmeier C, Danson S, Jones R. PMID: 42213481 [PubMed - indexed for MEDLINE]
	Fusobacterium nucleatum in cancer: Interactions with microbiota, tumour colonisation and cancer progression. Clin Transl Med Zhao F, An R, Yu S, Ma Y, Liu W, Sheng C, Xie X, Zhang J. PMID: 42212696 [PubMed - indexed for MEDLINE]
	Neutrophil Extracellular Traps in Pancreatic Ductal Adenocarcinoma: A Vicious Cycle in the Tumor Microenvironment and Targeted Interventions. Int J Biol Sci Zhao L, Yuan H, Chen Z, Xia X, Tian X, Wang S. PMID: 42212337 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 60271

Seite 1 von 3014



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung